0
Phathom Pharmaceuticals, Inc. Banner Image

Phathom Pharmaceuticals, Inc.

  • Ticker PHAT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Phathom Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Florham Park, New Jersey
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders.
REPORT RATINGS
4.8 / 5.0 (148)

Phathom Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 148 reviews.

Phathom Pharmaceuticals, Inc.

Most Recent Annual Report

Phathom Pharmaceuticals, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Phathom Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!